等待開盤 02-20 09:30:00 美东时间
-0.110
-0.17%
On CNBC's "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors recommended staying long on AbbVie.
01-28 21:20
Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.
2025-11-18 21:08
Shares of healthcare stocks are trading lower after the US Senate approved a de...
2025-11-11 00:12
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
2025-10-18 04:13
Trivariate Research founder and CEO Adam Parker maintains an optimistic market outlook, citing AI productivity, dovish Federal Reserve policies, and increased market activity as key pillars supporting...
2025-10-16 02:02
Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.
2025-09-22 21:11
At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for Biologics Evaluation and Research, just ten days after departing the agenc...
2025-08-10 04:46
Health insurance companies have raised concerns that tariffs could lead to higher premiums for enrollees in the individual and small group markets next year.
2025-06-19 18:05
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.
2025-02-25 23:50